LifeTech Scientific (HKG:1302) reported a profit attributable to owners of 55.1 million yuan for the first half of 2025, down from 205.6 million yuan a year earlier, according to a Friday Hong Kong bourse filing.
Earnings per share came in at 0.013 yuan, compared with 0.046 yuan in the prior-year period.
Revenue rose to 676.7 million yuan from 652.8 million yuan.
The board did not recommend an interim dividend.
Shares of the medical device manufacturer were down nearly 2% in Friday afternoon trade.